#duchennegenetherapy
🎙️ Today on Endpoints News Post-Hoc Live, we're talking about Sarepta. @drewsnews.bsky.social will be joined at 1:30pm ET by @jaredwhitlock.bsky.social and @leileiwu.bsky.social about the company's showdown with the FDA over its #duchennegenetherapy. Watch live here: endpoints.news/endpoints-li...
Live at 1:30 p.m. ET: What happens next with Sarepta and its showdown with the FDA?
Sarepta Therapeutics faces layoffs, reports third patient death, and FDA conflict over Duchenne gene therapy; reporters to discuss developments in live session.
endpoints.news
July 21, 2025 at 3:23 PM